Patient characteristics
| No. of patients | 847 |
| Age at end of follow-up, y* | 43 (11-87) |
| Male sex, no. (%) | 799 (94) |
| Diagnosis, no. (%) | |
| Hemophilia A | 640 (76) |
| Hemophilia B | 127 (15) |
| Other | 80 (9) |
| Total no. of deaths | 199 (24) |
| Cause of death, no. (%)† | |
| AIDS | 73 (37) |
| Liver-related | 55 (28) |
| Other | 71 (36) |
| Hepatitis C genotype, no. (%)‡ | |
| Type 1 | 361 (53) |
| Type 2-5 | 179 (27) |
| Missing | 147 (20) |
| Time from HCV infection to end of follow-up, y | 27 (3-42) |
| ESLD, no. | 71 |
| Liver failure | 59 |
| Hepatocellular carcinoma | 13 |
| Liver transplantation | 9 |
| Liver-related death | 55 |
| Coinfection with HIV, no. (%) | 210 (25) |
| HIV treatment | 161 of 210 (77) |
| HAART§ | 78 of 116 (67) |
| History of alcohol abuse, no. (%) | 70 (8) |
| No. of patients | 847 |
| Age at end of follow-up, y* | 43 (11-87) |
| Male sex, no. (%) | 799 (94) |
| Diagnosis, no. (%) | |
| Hemophilia A | 640 (76) |
| Hemophilia B | 127 (15) |
| Other | 80 (9) |
| Total no. of deaths | 199 (24) |
| Cause of death, no. (%)† | |
| AIDS | 73 (37) |
| Liver-related | 55 (28) |
| Other | 71 (36) |
| Hepatitis C genotype, no. (%)‡ | |
| Type 1 | 361 (53) |
| Type 2-5 | 179 (27) |
| Missing | 147 (20) |
| Time from HCV infection to end of follow-up, y | 27 (3-42) |
| ESLD, no. | 71 |
| Liver failure | 59 |
| Hepatocellular carcinoma | 13 |
| Liver transplantation | 9 |
| Liver-related death | 55 |
| Coinfection with HIV, no. (%) | 210 (25) |
| HIV treatment | 161 of 210 (77) |
| HAART§ | 78 of 116 (67) |
| History of alcohol abuse, no. (%) | 70 (8) |